Work Injury Prevention in Law Enforcement Officials

July 1, 2015 updated by: University of the Pacific

Effectiveness of an Exercise-based Work Injury Prevention Program in Law Enforcement Officials

Law enforcement officials (LEOs) demonstrate an elevated risk for occupational injury. The effectiveness of exercise-based work injury prevention programs (WIPPs) to reduce the risk and costs associated with occupational injury has yet to be tested rigorously in LEOs. The accuracy of existing field tests of physical functioning to predict occupational injuries and related expenses remains unclear. The objectives of this study are to: (i) determine the effect of an exercise-based WIPP on occupational wellness and productivity in a cohort of LEOs, and (ii) to determine the accuracy of 2 common field assessments of physical function to predict lost work productivity and related expenses in a cohort of LEOs.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Suspended

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Anticipated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
108

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • Chico, California, United States, 95928
        • Butte Premier Physical Therapy
      • Davis, California, United States, 95618
        • Physical Edge
      • Lodi, California, United States, 95240
        • PUMP Institute
      • Lodi, California, United States, 95242
        • Lodi Physical Therapy
      • Stockton, California, United States, 95211
        • University of the Pacific

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age between 18 and 60 years
  • Working full duty as a law enforcement official

Exclusion Criteria:

  • Current history of pathology or symptoms that preclude exercise
  • Medical or rehabilitative treatment for a work-related injury within the past year prior to enrollment in this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Exercise
Exercise will occur 3 times weekly for 6 months in 20-minute exercise sessions. Sessions will take place independently. Follow-up and progression of the home program will be completed in person or by video teleconferencing at regular intervals throughout the intervention phase.
Other: Exercise

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Number of Work Injury Claims During the Study Period
Time Frame: One time, at one year following enrollment into the study
One time, at one year following enrollment into the study
Medical Expenditures Related to Work Injury Claims During the Study Period
Time Frame: One time, at one year following enrollment into the study
One time, at one year following enrollment into the study
Number of Missed Work Days Due to Illness or Injury
Time Frame: One time, at one year following enrollment into the study
One time, at one year following enrollment into the study
Work Productivity and Activity Impairment Questionnaire - General Health Subscale
Time Frame: Weekly, up to one year following enrollment into the study
The Work Productivity and Activity Impairment (WPAI) Questionnaire was developed to measure the personal and economic effects of lost workplace productivity in the context of clinical trials. In this study, the WPAI-General Health (GH) version will be used in order to assess lost productivity and wellness during the study period. The WPAI-GH is a 6-item scale that solicits the number of hours missed from work and level of functional impairment perceived at work during the previous week. Four scores are calculated from the WPAI-GH, including percentage of work time missed due to health, percentage impairment while working due to health, percentage activity impairment due to health, an overall percentage work impairment. Time series data will be collected to observe trends over time that may relate to independent variables in this study, as well as to examine for previously unknown and uncontrolled variation (ie, seasonal variability).
Weekly, up to one year following enrollment into the study

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Functional Movement Screen
Time Frame: One time, at 3 months following enrollment into the study
The purpose of the Functional Movement Screen (FMS) is to provide the clinician with a rapid triage for potentially problematic regions that can contribute to symptoms, disablement, or injury. As a triage tool, FMS is used to determine regions that require additional clinical investigation. The FMS is a battery of 7 tests that are intended as an integrated assessment for limitations in range of motion, weakness, and incoordination. FMS tests consider spine, upper extremity, and lower extremity movements in the context of their respective regional kinetic chain. Component tests of the FMS involve rating of performance by a standardized examiner on a 3-point scale, and specific criteria exist for each rating. A composite score for the FMS may be calculated by summing the item scores.
One time, at 3 months following enrollment into the study
Star Balance Excursion Test
Time Frame: One time, at 3 months following enrollment into the study
The Star Excursion Balance Test is a clinical test of dynamic balance. Subjects will assume unilateral stance in the center of a grid marked circumferentially in 45-degree increments. After a learning trial consisting of 6 repetitions in each of the 8 test directions, subjects will complete 3 repetitions of single limb squat reach. The evaluating therapist will record the distance achieved between the stance toe and heel of the reaching extremity in each of 3 repetitions in each direction.
One time, at 3 months following enrollment into the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of the Pacific

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 1, 2012

Primary Completion (Anticipated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 1, 2015

Study Completion (Anticipated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 1, 2015

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 3, 2012

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 11, 2013

First Posted (Estimate)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 14, 2013

Study Record Updates

Last Update Posted (Estimate)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
July 2, 2015

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 1, 2015

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
July 1, 2015

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • UPacific_Davenport1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings